Answer
Aug 27, 2025 - 09:19 AM
Selegiline, marketed under the brand name Eldepryl, is a selective monoamine oxidase B (MAO-B) inhibitor. It is primarily used in the management of Parkinson's disease, where it helps increase and prolong the effects of dopamine in the brain. By inhibiting the breakdown of dopamine, selegiline can help improve motor symptoms associated with Parkinson's disease.
